{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:19:01Z","timestamp":1762298341811},"reference-count":27,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.15-276","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T22:26:08Z","timestamp":1452205568000},"page":"30-34","source":"Crossref","is-referenced-by-count":5,"title":["Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients"],"prefix":"10.1536","volume":"57","author":[{"given":"Hideki","family":"Koike","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Yuzawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzaburo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003; 41: 255-62.","DOI":"10.1016\/S0735-1097(02)02705-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dusman RE, Stanton MS, Miles WM, <i>et al<\/i>. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990; 82: 51-9.","DOI":"10.1161\/01.CIR.82.1.51"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998; 98: 2574-9.","DOI":"10.1161\/01.CIR.98.23.2574"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pitcher WD. Amiodarone pulmonary toxicity. Am J Med Sci 1992; 303: 206-12. (Review)","DOI":"10.1097\/00000441-199203000-00012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Komatsu T, Tachibana H, Sato Y, Ozawa M, Kunugita F, Nakamura M. Long-term efficacy of amiodarone therapy for the prevention of recurrence of paroxysmal atrial fibrillation. Analysis based on patient characteristics. Int Heart J 2011; 52: 212-7.","DOI":"10.1536\/ihj.52.212"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jackevicius CA, Tom A, Essebag V, <i>et al<\/i>. Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol 2011; 108: 705-10.","DOI":"10.1016\/j.amjcard.2011.04.024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamada T, Murakami Y, Okada T, <i>et al<\/i>. Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation. Int Heart J 2008; 49: 143-51.","DOI":"10.1536\/ihj.49.143"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest 1988; 93: 1067-75. (Review)","DOI":"10.1378\/chest.93.5.1067"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 2013; 48: 452-8.","DOI":"10.1038\/bmt.2012.244"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dunn M, Glassroth J. Pulmonary complications of amiodarone toxicity. Prog Cardiovasc Dis 1989; 31: 447-53. (Review)","DOI":"10.1016\/0033-0620(89)90019-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Latini R, Tognoni G, Kates RE. Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet 1984; 9: 136-56. (Review)","DOI":"10.2165\/00003088-198409020-00002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rakita L, Sobol SM, Mostow N, Vrobel T. Amiodarone pulmonary toxicity. Am Heart J 1983; 106: 906-16. (Review)","DOI":"10.1016\/0002-8703(83)90015-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fraire AE, Guntupalli KK, Greenberg SD, Cartwright J Jr, Chasen MH. Amiodarone pulmonary toxicity: a multidisciplinary review of current status. South Med J 1993; 86: 67-77. (Review)","DOI":"10.1097\/00007611-199301000-00014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kowey PR, Friehling TD, Marinchak RA, Sulpizi AM, Stohler JL. Safety and efficacy of amiodarone. The low-dose perspective. Chest 1988; 93: 54-9.","DOI":"10.1378\/chest.93.1.54"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ott MC, Khoor A, Leventhal JP, Paterick TE, Burger CD. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 2003; 123: 646-51.","DOI":"10.1378\/chest.123.2.646"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sato K, Miyakawa M, Eto M, <i>et al<\/i>. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. Endocr J 1999; 46: 443-51.","DOI":"10.1507\/endocrj.46.443"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest 1988; 93: 1242-8. (Review)","DOI":"10.1378\/chest.93.6.1242"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Quaglino D, Ha HR, Duner E, <i>et al<\/i>. Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship. Am J Physiol Lung Cell Mol Physiol 2004; 287: L438-47.","DOI":"10.1152\/ajplung.00434.2003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD. Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 1987; 147: 50-5.","DOI":"10.1001\/archinte.1987.00370010054014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Akoun GM, Gauthier-Rahman S, Milleron BJ, Perrot JY, Mayaud CM. Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism. Chest 1984; 85: 133-5.","DOI":"10.1378\/chest.85.1.133"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Martin WJ 2nd. Mechanisms of amiodarone pulmonary toxicity. Clin Chest Med 1990; 11: 131-8. (Review)","DOI":"10.1016\/S0272-5231(21)00677-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pollak PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol 1999; 84: 37R-45R. (Review)","DOI":"10.1016\/S0002-9149(99)00700-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Fukuchi H, Nakashima M, Araki R, <i>et al<\/i>. Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis. J Clin Pharm Ther 2009; 34: 329-36.","DOI":"10.1111\/j.1365-2710.2008.00987.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Goh VH, Tain CF, Tong TY, Mok HP, Wong MT. Are BMI and other anthropometric measures appropriate as indices for obesity? A study in an Asian population. J Lipid Res 2004; 45: 1892-8.","DOI":"10.1194\/jlr.M400159-JLR200"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN Jr. Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 1994; 60: 23-8.","DOI":"10.1093\/ajcn\/60.1.23"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kim SH, Chung JH, Kwon BJ, Song SW, Choi WS. The associations of epicardial adipose tissue with coronary artery disease and coronary atherosclerosis. Int Heart J 2014; 55: 197-203.","DOI":"10.1536\/ihj.13-303"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yoshimura A, Adachi H, Hirai Y, <i>et al<\/i>. Serum uric acid is associated with the left ventricular mass index in males of a general population. Int Heart J 2014; 55: 65-70.","DOI":"10.1536\/ihj.13-170"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/1\/57_15-276\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T04:34:16Z","timestamp":1654058056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/1\/57_15-276\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.15-276","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}